Free Trial

Medicenna Therapeutics (MDNA) Competitors

Medicenna Therapeutics logo
C$2.51
+0.15 (+6.36%)
(As of 11/1/2024 ET)

MDNA vs. TEV, ABT, NOT, PYR, NVO, DNA, SLS, VBV, CUS, and APM

Should you be buying Medicenna Therapeutics stock or one of its competitors? The main competitors of Medicenna Therapeutics include Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), Dalradian Resources (DNA), Solaris Resources (SLS), VBI Vaccines (VBV), Chemtrade Electrochem Inc, (CUS), and Andean Precious Metals (APM). These companies are all part of the "pharmaceutical products" industry.

Medicenna Therapeutics vs.

Tervita (TSE:TEV) and Medicenna Therapeutics (TSE:MDNA) are both small-cap industrials companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, media sentiment, dividends, profitability, institutional ownership and valuation.

Given Tervita's higher probable upside, equities research analysts clearly believe Tervita is more favorable than Medicenna Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tervita
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Medicenna Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Tervita has higher revenue and earnings than Medicenna Therapeutics. Medicenna Therapeutics is trading at a lower price-to-earnings ratio than Tervita, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TervitaC$1.36B0.00-C$1.04M-C$0.01N/A
Medicenna TherapeuticsN/AN/A-C$26.24M-C$0.38-6.61

Medicenna Therapeutics received 48 more outperform votes than Tervita when rated by MarketBeat users. Likewise, 68.22% of users gave Medicenna Therapeutics an outperform vote while only 50.63% of users gave Tervita an outperform vote.

CompanyUnderperformOutperform
TervitaOutperform Votes
40
50.63%
Underperform Votes
39
49.37%
Medicenna TherapeuticsOutperform Votes
88
68.22%
Underperform Votes
41
31.78%

13.0% of Medicenna Therapeutics shares are held by institutional investors. 22.6% of Medicenna Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Tervita's average media sentiment score of 0.00 equaled Medicenna Therapeutics'average media sentiment score.

Company Overall Sentiment
Tervita Neutral
Medicenna Therapeutics Neutral

Tervita's return on equity of 0.00% beat Medicenna Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
TervitaN/A N/A N/A
Medicenna Therapeutics N/A -105.43%-32.80%

Summary

Tervita beats Medicenna Therapeutics on 6 of the 11 factors compared between the two stocks.

Get Medicenna Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for MDNA and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MDNA vs. The Competition

MetricMedicenna TherapeuticsBiotechnology IndustryMedical SectorTSE Exchange
Market CapC$191.84MC$158.40MC$5.40BC$5.94B
Dividend YieldN/A3.39%5.16%5.37%
P/E Ratio-6.61348.23113.0925.87
Price / SalesN/A19,806.471,478.841,515.70
Price / Cash1.1511.3039.8381.06
Price / Book8.377.514.643.11
Net Income-C$26.24M-C$18.90MC$119.13MC$292.76M
7 Day Performance6.81%-0.05%0.78%-1.65%
1 Month Performance19.52%2.54%5.66%2.32%
1 Year Performance904.00%28.85%36.92%45.73%

Medicenna Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDNA
Medicenna Therapeutics
N/AC$2.51
+6.4%
N/A+1,040.9%C$191.84MN/A-6.6120
TEV
Tervita
N/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap Up
ABT
Absolute Software Co. (ABT.TO)
N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000News Coverage
High Trading Volume
NOT
Noront Resources
N/AC$1.10
-0.5%
N/A+0.0%C$612.18MN/A-7.20101,700
PYR
PyroGenesis Canada Inc. (PYR.V)
N/AC$3.85
+11.0%
N/A+0.0%C$606.96MC$6.01M-154.0090Gap Up
NVO
Novo Resources Corp. (NVO.V)
N/AC$2.38
-0.4%
N/A+0.0%C$548.24MN/A-21.2554,400
DNA
Dalradian Resources
N/AN/AN/AN/AC$519.02MN/A-56.15640
SLS
Solaris Resources
1.9495 of 5 stars
C$3.13
+2.0%
C$13.50
+331.3%
-39.3%C$507.81MN/A-6.9610Gap Up
VBV
VBI Vaccines
N/AN/AN/AN/AC$308.86MC$3.36M-4.9722
CUS
Chemtrade Electrochem Inc,
N/AN/AN/AN/AC$306.50MN/A0.0060
APM
Andean Precious Metals
0.7571 of 5 stars
C$1.76
-1.1%
C$1.70
-3.4%
N/AC$262.87MC$199.84M4.6330Analyst Upgrade
Positive News

Related Companies and Tools


This page (TSE:MDNA) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners